Core Viewpoint - Despite the strong performance of technology and pharmaceutical funds, public funds are gradually adopting a defensive mindset [1] Group 1: ETF Construction Strategies - The construction speed of popular industry ETFs has slowed down as stock prices heat up [4] - As of September 19, 2023, the strongest technology fund has achieved a performance of 196%, while the strongest pharmaceutical fund has exceeded 170% [5] - The construction speed of ETFs is influenced by the performance of the underlying sectors, with slower construction in sectors that have seen rapid price increases [5][6] Group 2: Shift to New Consumption - Head funds are increasingly participating in new consumption IPOs, indicating a strategic shift towards defensive assets [7] - Notable new consumption companies, such as IFBH, have attracted significant public fund interest, reflecting a growing focus on consumer stocks [8] - The new consumption sector is seen as a core defensive asset due to its relatively stable stock performance and emerging growth drivers [9] Group 3: Market Outlook and Investment Logic - The third quarter of 2023 is expected to be a period of market differentiation, with a focus on selecting quality companies [10] - Analysts suggest that the new consumption sector is gaining traction due to its emphasis on consumer experience and the emergence of leading brands in the capital market [10] - The consumption sector is anticipated to benefit from clearer demand-side policies in the second half of the year, leading to improved profitability [11]